Center for Infectious Disease Research nibbles at malaria vaccine

Carlye Skinner / January 4, 2017

Center for Infectious Disease Research (client) recently spoke with The Seattle Times about their milestone in developing a vaccine for malaria. Stefan Kappe and his team created a weakened form of the parasite to use as a basis for the vaccine. While this idea isn’t new, their approach certainly is; instead of syringes, they use living mosquitoes to inject the weakened parasites into their volunteers. The next round of human trials will begin later this year and will be a crucial test of the vaccine concept.

For more details, check out The Seattle Times article here.

Carlye Skinner

Executive Assistant

Carlye is an administrative professional with experience in social media marketing, customer relations and brand management. After spending four years earning her degree in psychology from the University of Washington, Carlye joined the marketing team at El Gaucho Hospitality where her love for hospitality and marketing grew. Her degree in psychology and involvement in the restaurant business give her a unique perspective on building meaningful relationships with clients and consumers alike. She thrives in fast-paced environments and is a self-proclaimed organization nerd (a label maker is a must).

You will always find Carlye with a cup of coffee in her hand. In her spare time she enjoys photography, playing disc golf, and watching Friends re-runs with her Cavalier King Charles Spaniel, Piper.